For the Inventor, By the Inventor

Enter assignee name

Austin, TX, United States of America

Asuragen, Inc.

USPTO Granted Patents = 31

% Expired Patents = 67.7

CIPO Patents = 2

EPO Patents = 35

Trademarks = 8

Forward Citations = 463

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

David Allen Brown (19 out of 74 patents)

Eric Devroe (13 out of 14 patents)

Kevin Kelnar (12 out of 20 patents)

4. Mike Byrom (10 out of 19 patents)

5. Dmitriy Ovcharenko (10 out of 17 patents)

6. Lance Ford (10 out of 14 patents)

7. Angie Cheng (10 out of 12 patents)

8. Rich Jarvis (10 out of 11 patents)

9. Gary J Latham (9 out of 17 patents)

10. Emmanuel Labourier (8 out of 8 patents)

11. Jeffrey Shelton (8 out of 10 patents)

12. Kerri Keiger (6 out of 6 patents)

13. Jaclyn Shingara (6 out of 6 patents)

14. Liangjing Chen (5 out of 8 patents)

15. Sachin Sah (5 out of 5 patents)

Core Competencies:

RNA Amplification

Nucleic Acid Detection

MicroRNA

PCR Methods

Genotyping

Biomarkers

Angiogenesis

Cervical Cancer

Prostate Disease

GC-Rich DNA

Normalization

Repeat Sequences

31 patents: Sort by Forward Citations

1. 12139755 - Methods of RNA amplification (2024-11-12),

2. 11913068 - Methods for nucleic acid size detection of repeat sequences (2024-02-27),

3. 11236384 - Methods of RNA amplification (2022-02-01),

4. 11214829 - Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating A/T-rich segments (2022-01-04),

5. 10047388 - Methods and compositions involving MicroRNA (2018-08-14),

6. 9783848 - PCR methods for characterizing the 5' untranslated region of the FMR1 and FMR2 genes (2017-10-10),

7. 9777330 - mPCR methods for analyzing repeat sequences (2017-10-03),

8. 9540645 - Compositions and methods related to miRNA modulation of neovascularization or angiogenesis (2017-01-10),

9. 9506061 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-11-29),

10. 9447414 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-09-20),

11. 9382537 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-07-05),

12. 9371560 - Comprehensive FMR1 genotyping (2016-06-21),

13. 9080215 - MicroRNAs differentially expressed in cervical cancer and uses thereof (2015-07-14),

14. 9068219 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2015-06-30),

15. 9051571 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2015-06-09),

Company Overview

Asuragen, Inc. is a biotechnology company based in Austin, Texas, specializing in the development of molecular diagnostic products and services. The organization focuses on providing innovative solutions for the detection and monitoring of genetic diseases and cancers, leveraging advanced technologies in molecular biology and genomics. Asuragen's expertise encompasses a range of applications, including RNA analysis and next-generation sequencing, aimed at enhancing patient care through precise and reliable testing methodologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

31 Patents

#101 in Austin, TX

#599 in Texas

#10,921 in US

#21,238 in the World

Austin, TX, United States of America

Asuragen, Inc.

Forward Citations = 463

35 inventors:

David Allen Brown (19 out of 74 patents)

Eric Devroe (13 out of 14 patents)

Kevin Kelnar (12 out of 20 patents)

4. Mike Byrom (10 out of 19 patents)

5. Dmitriy Ovcharenko (10 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Asuragen, Inc.. Retrieved from https://idiyas.com/company/asuragen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…